Postpartum haemorrhage (PPH) causes preventable maternal deaths, mainly in low-income
countries. Misoprostol has powerful uterotonic effects and, because it is well absorbed orally …

Introduction: Uterotonic drugs are recommended for the prevention and treatment of
postpartum hemorrhage (PPH), and oxytocin is considered the gold standard for both …

Background Postpartum haemorrhage remains an important cause of maternal death
despite treatment with conventional therapy. Uncontrolled studies and one randomised …

As a stable, orally active and cheap uterotonic, misoprostol would appear ideally suited to
the prevention of postpartum hemorrhage (PPH) in the developing world. Following …

OBJECTIVE: To review maternal deaths and the dose-related effects of misoprostol on blood
loss and pyrexia in randomized trials of misoprostol use for the prevention or treatment of …

Background: Postpartum haemorrhage (PPH) is a leading cause of maternal mortality
especially in the developing world. Misoprostol, a highly effective drug is highly effective in …

Misoprostol is an effective and safe uterotonic for the prevention and treatment of postpartum
hemorrhage (PPH). A 600‐μg oral dose of misoprostol has been shown to prevent PPH in …

Objective To investigate the use of the oral prostaglandin E1 analogue, misoprostol in the
prevention of postpartum haemorrhage. Design A prospective observational study. Setting A …

Objective: To assess misoprostol's ability to prevent postpartum hemorrhage (PPH) where
no alternatives exist. Comparison to oxytocics demonstrates how similarly misoprostol …

Postpartum haemorrhage remains a leading cause of maternal mortality, despite treatment
with conventional methods. In this randomised controlled trial, we compared misoprostol …